Sign In
Buy LGND
$234.40
+1.64 (+0.705%)
At Close: Jun 03, 2026
Ligand to Report Third Quarter 2024 Financial Results on November 7, 2024
04:01pm, Wednesday, 23'rd Oct 2024
JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report third quarter 2024 financial results before the opening of the U.S. financial mar
JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Travere Therapeutics, Inc. (Nasdaq: TVTX) has received full approval from the U.S. F
Dublin, Aug. 30, 2024 (GLOBE NEWSWIRE) -- The "Global CD40 Ligand Market by Type (Monoclonal Antibody, Polyclonal Antibody), Application (Autoimmune Disease Treatment, Immunotherapy, Vaccine Developme
Ligand Pharmaceuticals Incorporated (LGND) Q2 2024 Earnings Call Transcript
10:58pm, Tuesday, 06'th Aug 2024
Ligand Pharmaceuticals Incorporated (NASDAQ:LGND ) Q2 2024 Earnings Conference Call August 6, 2024 4:30 PM ET Company Participants Todd Davis - CEO Tavo Espinoza - CFO Paul Hadden - Senior Vice Presid
Ligand Pharmaceuticals: Solid Performer Performing Solidly
02:43pm, Monday, 29'th Jul 2024
Ligand Pharmaceuticals has seen over a 50% increase in share value since its Q1 earnings report. Recent positive developments include new deals, regulatory successes, and raising 2024 guidance. A new
Ligand to Report Second Quarter 2024 Financial Results on August 6, 2024
04:01pm, Tuesday, 23'rd Jul 2024
JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it will report second quarter 2024 financial results after the close of the U.S. financial marke
5 Best Short-Term Stocks to Consider Investing In
09:01am, Wednesday, 10'th Jul 2024
Not every investor is in the market for the long haul. Some prefer short time frames and volatile stocks, looking to make a profit in days or weeks rather than years.
Ligand to Acquire APEIRON Biologics AG for $100 Million
07:00am, Monday, 08'th Jul 2024
JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that it has entered into a definitive agreement to acquire APEIRON Biologics AG, which holds royalty
JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its partner Verona Pharma plc has received approval from the U.S. Food and Drug Administration (
Ligand Collaborator Merck Receives FDA Approval for CAPVAXIVE™ (Pneumococcal 21-valent Conjugate Vaccine) for Adults
08:00am, Tuesday, 18'th Jun 2024
JUPITER, Fla.--(BUSINESS WIRE)--Ligand Pharmaceuticals Incorporated (Nasdaq: LGND) today announced that its collaborator Merck, known as MSD outside the United States and Canada, has received approval
What Makes Ligand (LGND) a New Strong Buy Stock
01:01pm, Friday, 14'th Jun 2024
Ligand (LGND) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Why Is Ligand (LGND) Up 4% Since Last Earnings Report?
12:35pm, Thursday, 06'th Jun 2024
Ligand (LGND) reported earnings 30 days ago. What's next for the stock?
New Strong Buy Stocks for June 6th
07:56am, Thursday, 06'th Jun 2024
HWM, LGND, MATX, SMFKY and HAE have been added to the Zacks Rank #1 (Strong Buy) List on June 6, 2024.
Does Ligand (LGND) Have the Potential to Rally 32.33% as Wall Street Analysts Expect?
10:56am, Tuesday, 04'th Jun 2024
The average of price targets set by Wall Street analysts indicates a potential upside of 32.3% in Ligand (LGND). While the effectiveness of this highly sought-after metric is questionable, the positiv
Recent Price Trend in Ligand (LGND) is Your Friend, Here's Why
09:52am, Tuesday, 04'th Jun 2024
Ligand (LGND) could be a solid choice for shorter-term investors looking to capitalize on the recent price trend in fundamentally sound stocks. It is one of the many stocks that passed through our sho
